Karolina Radziejewska

Ms. Karolina Radziejewska

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2026 in International Journal for Parasitology: Drugs and Drug Resistance
Verified
Journal Article
Open access
ZNZofia Nowek
Zofia Nowek
MMMarcin Mickiewicz
Marcin Mickiewicz
AAAlistair Antonopoulos
Alistair Antonopoulos
APAdrian-Valentin Potărniche
Adrian-Valentin Potărniche
KBKinga Biernacka
Kinga Biernacka
JKJarosław Kaba
Jarosław Kaba
Benzimidazole resistance in Haemonchus contortus represents a widespread challenge in small ruminant production worldwide. Benzimidazoles remain one of the most commonly used drug classes, due to their broad spectrum of activity, affordability, and ease of administration. However, extensive and often inappropriate use of these compounds has led to the rapid emergence and global spread of resistance, particularly in H. contortus, a highly pathogenic and genetically diverse gastrointestinal nematode. Resistance to benzimidazoles is primarily associated with point mutations in the isotype-1 β-tubulin gene, most notably at codons 167 (F167Y), 198 (E198A), and 200 (F200Y), which result in modifications to the β-tubulin that prevent drug binding and compromise treatment efficacy. This review summarises the molecular mechanisms underlying benzimidazole resistance and provides an overview of currently available diagnostic approaches, including in vivo and in vitro assays, as well as molecular techniques such as real-time PCR, digital PCR, pyrosequencing, deep amplicon sequencing, and isothermal amplification methods. Despite regional variation in the distribution of resistance-associated polymorphisms, there is a consistent global predominance of the F200Y mutation. Finally, this review highlights the importance of integrating molecular surveillance with sustainable parasite control strategies to slow the further spread of benzimidazole resistance and preserve the long-term efficacy of available anthelmintics.

15 February 2026 in Animals
Verified
Journal Article
Open access
PDF file
Dawid JańczakDawid Jańczak
Dawid Jańczak
AMAgata Moroz
Agata Moroz
KRKarolina Radziejewska
Karolina Radziejewska
AMAleksandra Kornelia Maj
Aleksandra Kornelia Maj
PGPiotr Górecki
Piotr Górecki
OSOlga Szaluś-Jordanow
Olga Szaluś-Jordanow
Background: Pulmonary nematodes are an underrecognized cause of respiratory disease in domestic cats, with diagnosis often complicated by nonspecific clinical signs and limitations of fecal-based testing. Methods: This study aimed to assess the prevalence of feline lungworms in Poland and to describe lung ultrasound findings in a separate clinical cohort of cats. A nationwide coprological survey was conducted using pooled fecal samples from 1058 cats examined with Baermann and flotation techniques, supported by molecular diagnostics where available. Results: Overall, 9.83% of cats were positive for at least one parasite. Aelurostrongylus abstrusus was the most frequently detected lungworm (7.18%), followed by Eucoleus aerophilus (2.17%) and Troglostrongylus brevior (0.47%). Lungworm infections were strongly associated with younger age and showed marked seasonal variation, with higher prevalence in autumn and winter. Lung ultrasound consistently revealed diffuse B-line artifacts and other signs of reduced lung aeration, often in the absence of severe respiratory signs. Following treatment with topical imidacloprid/moxidectin, complete resolution of ultrasonographic abnormalities and clinical signs was observed. Conclusions: These findings confirm that feline pulmonary nematodes are present in Poland and may be underdiagnosed. Lung ultrasound represents a sensitive and non-invasive tool for detecting and monitoring lung involvement, but should be interpreted in conjunction with epidemiological data, parasitological results and therapeutic response.

24 October 2026 in Methods and Protocols
Verified
Journal Article
Open access
PDF file
AGAnna Golke
Anna Golke
OSOlga Szaluś-Jordanow
Olga Szaluś-Jordanow
TDTomasz Dzieciatkowski
Tomasz Dzieciatkowski
Dawid JańczakDawid Jańczak
Dawid Jańczak
AMAgata Moroz
Agata Moroz
LRLukasz Rabalski
Lukasz Rabalski
Recent reports indicate a growing number of A/H5N1 infections in companion animals and wildlife, particularly across Europe and the United States and, most recently, in Australia, where the virus poses a potentially serious threat to endemic wildlife, including threatened species. In Poland, following an epizootic that occurred in summer 2023, A/H5N1 virus has continued to be detected in domestic animals showing clinical signs. Continued occurrence of mammalian infections remains possible, underscoring the need for reliable diagnostic approaches. Our experience suggests that A/H5N1 infection can remain challenging to diagnose even in animals with severe clinical signs and rapidly progressive, often fatal disease. In selected clinical and post-mortem samples, low viral RNA loads and/or the presence of tissue-derived PCR inhibitors can hamper amplification and subsequent sequencing. Nevertheless, by mid-2026, we had identified more than 40 A/H5N1 infections in dogs, cats, and ferrets, highlighting the continued need for sensitive molecular diagnostic approaches in mammalian cases. The optimized workflow enables robust downstream targeted Sanger sequencing of hemagglutinin (H5) and neuraminidase (N1) amplicons, providing a rapid diagnostic rescue approach for subtype confirmation and targeted genetic characterization. By refining diagnostic workflows for low-viral-load samples, this protocol enables molecular diagnostic confirmation of HPAI H5N1 subtype in companion animals.